Folleto
Synthgene's 3 monkeypox virus detection kits have also been approved by the EU CE certification
Tiempo de liberación:
2022-05-25
On May 24, Nanjing Synthgene Medical Technology Co., Ltd. (hereinafter referred to as "Synthgene") developed products "Monkeypox Virus Nucleic Acid Detection Kit (RT-PCR Method)", Monkeypox Virus Antigen Detection Kit (Colloidal Gold Method) ), monkeypox virus antibody detection kit (colloidal gold method) three products have obtained EU CE certificate at the same time, the approval of this series of products means that these kits can be sold in EU countries and countries that recognize EU CE certification, and can further It broadens the application fields of the company's products and responds more comprehensively to the needs of overseas markets.


Synthgene (Yixing) Health Technology Co., Ltd.
Synthgene (Yixing) Health Technology Co., Ltd. es una empresa de alta tecnología biomédica que se centra en el desarrollo y la producción de productos de la autoinspección del hogar de OTC. La compañía tiene una plataforma de tecnología madura, que incluye plataforma de cromatografía, plataforma de amplificación isotérmica, etc.
Contacte con nosotros
Dirección: Address: 2nd Floor,Area B and 4A02,4th Floor, Area A, Building 7,Yiyao Health Science and Technology Park, No.63 Science and Technology Avenue,Gaocheng Town, Yixing City,214200,China
Tel: 86 17721538411
Correo electrónico: info@syngenebio.com
Correo electrónico post-venta: service@syngenebio.com
Derechos de autor©Tecnología médica Co., Ltd. de Nanjing Synthgene |SEO| Desarrollado por:Www.300.cn
- Inquiry
